Delivery Order SPE2DB20D7059-SPE2DB25FGSF6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Omnipaque 300 mg/mL infusion bottles (100 mL units) under a firm fixed-price contract valued at $2,183.45. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 9, 2025. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,622.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for Omnipaque 300 mg/ml infusion bottles (100ml units). The contract, which is non-set-aside and competitively awarded, is scheduled for completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,582.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Omnipaque 180 mg/mL vials (10 mL units) on August 20, 2025, with a completion date of August 21, 2025. This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $2,282.49 to AmerisourceBergen Drug Corp for the supply of Omnipaque 300 mg/mL in 100 mL infusion bottles. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with performance based in Conshohocken, Pennsylvania, and an ultimate completion date of September 10, 2025. This delivery order represents a task issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $5,239.40 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Omnipaque 300 mg/ml in 100ml infusion bottles. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 15, 2025. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Omnipaque 180 mg/mL vials (10 mL units) with a ceiling value of $3,890.53. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by July 14, 2025, with performance at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Omnipaque 240 mg/mL vials (10 mL) with a ceiling value of $1,719.30 under a firm fixed price contract type. The award was made on September 4, 2025, with an ultimate completion date of September 5, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, consistent with the...
- The Defense Logistics Agency awarded a $1,306.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for OMNIPAQUE 300 mg/mL vials (10 mL units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,352.64 for Omnipaque 350 mg/ml Pluspak 500ml, a contrast agent used in diagnostic imaging procedures. The contract is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,381.60 to AmerisourceBergen Drug Corp for the supply of Omnipaque 350 mg/ml, a contrast media pharmaceutical product in 500ml Pluspak packaging. This firm fixed-price delivery order, awarded on July 24, 2025, represents a non-competitive, non-set-aside procurement with an ultimate completion date of July 25, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGSF6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,171.00 to AmerisourceBergen Drug Corp for the supply of Omnipaque 300 mg/ml infusion bottles (100 ml units). The contract, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that supports comprehensive pharmaceutical supply needs for military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a competitive awardee with no set-aside restrictions, the company demonstrates capability to fulfill diverse federal medical supply requirements through its extensive portfolio of brand-name and generic pharmaceuticals, specialty medications, vaccines, and medical devices. This specific delivery order for Omnipaque contrast media represents a routine fulfillment under the company's comprehensive global pharmaceutical support vehicle with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/17/25 |